Vigil Neuroscience, Inc.
VIGL
$7.95
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.94% | -6.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.55% | 21.46% | |||
| Operating Income | 6.55% | -21.46% | |||
| Income Before Tax | 5.95% | -23.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.95% | -23.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.95% | -23.75% | |||
| EBIT | 6.55% | -21.46% | |||
| EBITDA | 6.62% | -21.59% | |||
| EPS Basic | 14.96% | -20.54% | |||
| Normalized Basic EPS | 15.01% | -20.63% | |||
| EPS Diluted | 14.96% | -20.54% | |||
| Normalized Diluted EPS | 15.01% | -20.63% | |||
| Average Basic Shares Outstanding | 10.59% | 2.66% | |||
| Average Diluted Shares Outstanding | 10.59% | 2.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||